• Sonuç bulunamadı

Several factors can alter the QTc interval in patients with end-stage renal disease

N/A
N/A
Protected

Academic year: 2021

Share "Several factors can alter the QTc interval in patients with end-stage renal disease"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

889

Letters to the Editor

To the Editor,

I read with great interest the paper by Temiz et al. (1) entitled “Effects of cinacalcet treatment on QT interval in hemodialysis patients” published as Epub ahead of print for The Anatolian Journal of Cardiology 2015. They aimed to evaluate the effects of a calcimimetic drug (cinacalcet) on corrected QT values (QTc) in patients with end-stage renal disease (ESRD). They found a pro-longation of QTc value compared with baseline QTc value after cinacalcet treatment. I have a few comments.

QTc interval is the time from beginning of QRS to the end of T wave. In other words, it consists of depolarization and repolar-ization phases of cardiac tissue. Prolongation of QTc represents delayed cardiac repolarization and can be related to ventricular arrhythmias and sudden cardiac death (2, 3). Although it is well-known that QTc prolongation is common in patients with ESRD, the exact mechanism of this cardiac repolarization abnormal-ity has not been established (2–5). Hemodialysis is one reason QTc interval may be affected. Researchers have demonstrated increased QTc intervals in patients with ESRD, especially after end of hemodialysis. This is largely attributed to rapid changes in plasma electrolyte levels during hemodialysis (4). Therefore, it is crucial exactly when electrocardiography (ECG) is performed. In the study by Temiz et al. (1), it is possible that the timing of ECG may have influenced measurement of QTc.

Electrolyte disturbances are common in patients with ESRD and can cause changes in cardiac ionic polarization, resulting in altered QTc interval (2–5). Foglia et al. (5) determined QT pro-longation in patients with primary renal hypokalemia-hypomag-nesemia, and demonstrated that decreased levels of potassium and magnesium could alter duration of action potential in car-diac cell membrane. In the study by Temiz et al. (1), it may be helpful to present electrolyte levels of the patients at the time of ECG whether electrolytes have influential effects on QTc mea-surements or not.

Finally, measurement of QTc interval has some technical dif-ficulties such as presence of U waves or inverted T waves and intraobserver variability, which are not mentioned clearly in the study by Temiz et al. (1) and can affect the precise measurement of QTc value (2–5).

In conclusion, I think that this study would be stronger with these additional data mentioned above and we can easily under-stand the role of cinacalcet on QTc interval in patients with ESRD. Mustafa Gülgün

Department of Pediatric Cardiology, Gülhane Military Medical Academy (former name) Gülhane Training and Research Hospital (new name); Ankara-Turkey

References

1. Temiz G, Yalçın AU, Mutluay R, Bozacı İ, Bal C. Effects of cinacalcet treatment on QT interval in hemodialysis patients. Anatol J Cardiol 2015 Nov 25. Epub ahead of print.

2. Bolat E, Çelikbilek M, Sarıkaya S, Yılmaz YK, Doğan S, Özbakır Ö. Effects of balanced propofol sedation on QT, corrected QT, and P-wave dispersion on upper endoscopy. Anatol J Cardiol 2016; 16: 328-32.

3. Sherif KA, Abo-Salem E, Panikkath R, Nusrat M, Tuncel M. Cardiac repolarization abnormalities among patients with various stages of chronic kidney disease. Clin Cardiol 2014; 37: 417-21. Crossref

4. Mozos I. Laboratory markers of ventricular arrhythmia risk in renal failure. Biomed Res Int 2014; 2014: 509204. Crossref

5. Foglia PE, Bettinelli A, Tosetto C, Cortesi C, Crosazzo L, Edefonti A, et al. Cardiac work up in primary renal hypokalaemia-hypomag-nesaemia (Gitelman syndrome). Nephrol Dial Transplant 2004; 19: 1398-402. Crossref

Address for Correspondence: Dr. Mustafa Gülgün GATA (eski isim), Gülhane Eğitim ve Araştırma Hastanesi (yeni isim), Pediyatrik Kardiyoloji Anabilim Dalı, 06010 Etlik, Ankara-Türkiye

E-mail: mustafagulgun@yahoo.com, mgulgun@gata.edu.tr

©Copyright 2016 by Turkish Society of Cardiology - Available online at www.anatoljcardiol.com

DOI:10.14744/AnatolJCardiol.2016.7355

Author`s Reply

To the Editor,

Thanks for your interest. It is true that QTc interval may be altered by several factors including hemodialysis and electro-lyte disturbances. In our study, all electrocardiographic (ECG) measurements were taken just before initiation of dialysis ses-sion and all of the patients were undergoing maintenance he-modialysis for at least 12 months, so they were more resistant to antiarrhythmic effects of electrolyte disturbances than new patients to hemodialysis. We did not include patients who had any arrhythmia findings before or during the study, but unfortu-nately we did not record electrolyte measurements during ECG examination.

Second, we evaluated QTc interval according to Bazzet’s formula, but we did not evaluate intraobserver variability and we accept that this may be a limitation to our study.

Gökhan Temiz

Department of Nephrology, Faculty of Medicine, Eskişehir Osmangazi University; Eskişehir-Turkey

Address for Correspondence: Dr. Gökhan Temiz Eskişehir Osmangazi Üniversitesi

Tıp Fakültesi Nefroloji Anabilim Dalı 26140 Meselik, Eskişehir-Türkiye E-mail: gokhan_tem@hotmail.com

Several factors can alter the QTc interval

in patients with end-stage renal disease

Referanslar

Benzer Belgeler

The aim of the present study was to assess the ventricular repolarization by using the Tp–e interval, Tp–e/QT ratio, and Tp–e/QTc ratio as candidate markers of ventricular

Here, we report the case of a patient with par- oxysmal AF and end-stage renal disease (ESRD) requiring hemo- dialysis, in whom apixaban successfully and safely resolved a LAA

Objective: To evaluate ventricular repolarization parameters using the interval from the peak to the end of the T wave (Tp–Te), together with QT and corrected QT (QTc) intervals,

The primary aim of this pilot study was to examine the effects of lowering uric acid levels using allopurinol on lipoprotein markers of metabolic syndrome in patients.. Methods:

A huge intracardiac thrombus developed in the presence of antithrombin III deficiency in a patient with end-stage renal failure.. Son dönem böbrek yetersizliği olan hastada

Cardiac troponins have no prognostic value for acute and chronic cardiac events in asymptomatic patients with end-stage renal failure. Jishi F, Hudson PR, Williams CP, Jones

This study was a retrospective single-center study of 34 ESRD patients (hemodialysis patients, four patients lost to follow up leaving 30 patients) with femoropopliteal

Even there is no statistically signifi- cant difference between CRD and ESRD patients, be- ing significantly lower from the healthy volunteers sup- ports that pancreatic